April 30, 2026: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 04/30/2026

Apr 30, 2026

Confidence: VERIFIED The Center for Drug Evaluation and Research (CDER) has announced a meeting of the Oncologic Drugs Advisory Committee scheduled for April 30, 2026.

Confidence: VERIFIED The meeting will be held in a hybrid format, accommodating both in-person and virtual participation. The in-person location is Silver Spring, United States; the specific venue has not yet been confirmed.

Confidence: VERIFIED This is a regulatory advisory committee meeting convened under the FDA's advisory committee framework. Further details, including agenda items, specific venue address, and registration instructions, are available on the official FDA advisory committee calendar page.

About the Organiser

Center for Drug Evaluation and Research

Frequently Asked Questions

When is the Oncologic Drugs Advisory Committee meeting?

The meeting is scheduled for April 30, 2026. It is a single-day event.

Where will the Oncologic Drugs Advisory Committee meeting be held?

The meeting will be held in Silver Spring, United States. The specific venue is listed as TBD and has not yet been confirmed.

Is the meeting in-person or virtual?

The meeting is hybrid, meaning it will accommodate both in-person and virtual participation.

Who organises this advisory committee meeting?

The meeting is organised by the Center for Drug Evaluation and Research (CDER), a centre of the U.S. Food and Drug Administration (FDA).

How can I find registration or attendance details?

Further details are available via the official FDA event page at https://www.fda.gov/advisory-committees/advisory-committee-calendar/april-30-2026-meeting-oncologic-drugs-advisory-committee-meeting-announcement-04302026. No registration deadline or price information is available in the source.

Day and Timing

Thursday, Apr 30

Location

Entry Fees

Frequency

Annual

Event Type

Duration

1 Day

Website

fda.gov